Medicine and Dentistry
Patient
94%
Placebo
66%
Losartan
66%
COVID-19
66%
Randomized Clinical Trial
66%
Physician
50%
Randomized Controlled Trial
44%
Lung Injury
36%
Mortality
35%
Monotherapy
33%
Septic Shock
33%
Ascorbic Acid
33%
Shock (Circulatory)
33%
Acute Respiratory Distress Syndrome
33%
Anxiety
33%
Extracorporeal Membrane Oxygenation
33%
Therapeutic Procedure
30%
Assessment
20%
Combination Therapy
19%
Arm
17%
Systemic Vascular Resistance
16%
Pump
16%
Sensitivity and Specificity
16%
Heart Function
16%
Emergency
16%
Morbidity
16%
Hypertensive Factor
13%
Artificial Respiration
10%
Hospital
8%
Angiotensin II
8%
Cells
8%
Drug
7%
Chemotherapeutic Agent
7%
Inpatient
7%
Angiotensin Converting Enzyme 2
6%
Angiotensin Receptor Antagonist
6%
Disease
6%
Virus Entry
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Renin Angiotensin Aldosterone System
5%
Syndrome
5%
Patient Referral
5%
Rescue Therapy
5%
Sodium Chloride
5%
Analysis
5%
Nursing and Health Professions
Patient
100%
Losartan
66%
Mortality
47%
Lung Injury
36%
Shock
33%
Complication
33%
Emergency Ward
33%
Taxonomy
33%
Extracorporeal Oxygenation
33%
Placebo
33%
Adult Respiratory Distress Syndrome
33%
Outpatient
33%
Treatment Outcome
33%
Physician
33%
Length of Stay
33%
Odds Ratio
22%
Analysis
22%
Time
20%
Volume
16%
Malignant Neoplasm
16%
Cancer Therapy
16%
Combination Therapy
16%
Emergency Physician
16%
PIPES
16%
Systemic Vascular Resistance
16%
Pump
16%
Morbidity
16%
Hospital
13%
Adverse Event
11%
Hypertensive Factor
11%
Intensive Care Unit
11%
Community Hospital
11%
Adult
11%
All Cause Mortality
11%
Intensivist
11%
Hospital Mortality
11%
Hospitalization
10%
Virus Load
10%
Aldosterone
8%
Renin
8%
Angiotensin
8%
Quality of Life
8%
Follow up
8%
Spinal Cord Compression
8%
Angiotensin II
8%
Survival
8%
Drug Therapy
8%
Population
8%
Incidence
8%
Febrile Neutropenia
8%
Biochemistry, Genetics and Molecular Biology
Chromatin
100%
Transcription
74%
Chromatin Structure
66%
Poly ADP Ribose Polymerase
66%
Regulatory Mechanism
66%
DNA
33%
Long Noncoding RNA
33%
CTCF
33%
Enzyme Active Site
33%
DNA-binding Domain
33%
Protein
26%
DNA Sequence
22%
Cohesin
18%
Heterochromatin
14%
Nucleosome
13%
Enzyme Activity
11%
Protein-DNA Interaction
11%
Polymerase Chain Reaction
11%
Epigenetics
11%
Binding Site
11%
Copurification
11%
RNA
11%
Southern Blotting
11%
Epigenomics
11%
Antibody
11%
Protein Complexes
11%
Antibody Affinity
11%
Functional Genomics
11%
Serial Analysis of Gene Expression
11%
Association
11%
Euchromatin
11%
Comprehension
11%
Gene Activity
11%
Human Genome
11%
Adaptation
11%
Defense Mechanism
10%
Gene Expression
8%
Promoter Region
7%
